@article{Arendrup:2024:ofid/ofae372,
author = {Arendrup, MC and Armstrong-James, D and Borman, AM and Denning, DW and Fisher, MC and Gorton, R and Maertens, J and Martin-Loeches, I and Mehra, V and Mercier, T and Price, J and Rautemaa-Richardson, R and Wake, R and Andrews, N and White, PL},
doi = {ofid/ofae372},
journal = {Open Forum Infect Dis},
title = {The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective.},
url = {http://dx.doi.org/10.1093/ofid/ofae372},
volume = {11},
year = {2024}
}

Download

TY  - JOUR
AB  - Fungal diseases represent a considerable global health concern, affecting >1 billion people annually. In response to this growing challenge, the World Health Organization introduced the pivotal fungal priority pathogens list (FPPL) in late 2022. The FPPL highlights the challenges in estimating the global burden of fungal diseases and antifungal resistance (AFR), as well as limited surveillance capabilities and lack of routine AFR testing. Furthermore, training programs should incorporate sufficient information on fungal diseases, necessitating global advocacy to educate health care professionals and scientists. Established international guidelines and the FPPL are vital in strengthening local guidance on tackling fungal diseases. Future iterations of the FPPL have the potential to refine the list further, addressing its limitations and advancing our collective ability to combat fungal diseases effectively. Napp Pharmaceuticals Limited (Mundipharma UK) organized a workshop with key experts from Northern Europe to discuss the impact of the FPPL on regional clinical practice.
AU  - Arendrup,MC
AU  - Armstrong-James,D
AU  - Borman,AM
AU  - Denning,DW
AU  - Fisher,MC
AU  - Gorton,R
AU  - Maertens,J
AU  - Martin-Loeches,I
AU  - Mehra,V
AU  - Mercier,T
AU  - Price,J
AU  - Rautemaa-Richardson,R
AU  - Wake,R
AU  - Andrews,N
AU  - White,PL
DO  - ofid/ofae372
PY  - 2024///
SN  - 2328-8957
TI  - The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective.
T2  - Open Forum Infect Dis
UR  - http://dx.doi.org/10.1093/ofid/ofae372
UR  - https://www.ncbi.nlm.nih.gov/pubmed/39045012
VL  - 11
ER  - 

Download